Search research articles
Contact Us
Filters
Showing results (561-570 of 572) with videos related to
Page
of 58
Sort By:
Nature Communications
|
November 2, 2023
Follicle-stimulating hormone orchestrates glucose-stimulated insulin secretion of pancreatic islets
Yi Cheng, Hong Zhu, Jun Ren, et al.
Oncology Letters
|
October 29, 2021
MI-773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1
Yan-Ling Chen, Zi-Mu Zhang, Xiao-Lu Li, et al.
Cell & Bioscience
|
March 19, 2022
BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
Yan-Ling Chen, Xiao-Lu Li, Gen Li, et al.
Cancer Cell International
|
November 8, 2021
CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
You Jiang, Shui-Yan Wu, Yan-Ling Chen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 2, 2023
A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects
Xin-Mei Yang, Yang Yang, Bu-Fan Yao, et al.
The Lancet Regional Health. Western Pacific
|
November 6, 2023
Real-world tobacco cessation practice in China: findings from the prospective, nationwide multicenter China National Tobacco Cessation Cohort Study (CNTCCS)
Zhao Liu, Rui Qin, Xue-Jun Hu, et al.
JAMA
|
December 10, 2020
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial
Xi Wang, Shu-Sen Wang, Heng Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2020
An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy
Yun Wang, Yan-Yu Cai, Tobias Herold, et al.
Breast Cancer (Dove Medical Press)
|
April 17, 2024
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
Ying Chen, Wen-Xia Li, Jia-Hua Wu, et al.
BMJ Open
|
April 2, 2021
Study protocol for the Sino-Canadian Healthy Life Trajectories Initiative (SCHeLTI): a multicentre, cluster-randomised, parallel-group, superiority trial of a multifaceted community-family-mother-child intervention to prevent childhood overweight and obesity
Yanting Wu, Isabelle Marc, Luigi Bouchard, et al.
Page
of 58
Search research articles
Search
Showing results (561-570 of 572) with videos related to
Sort By:
Page
of 58
Nature Communications
|
November 2, 2023
Follicle-stimulating hormone orchestrates glucose-stimulated insulin secretion of pancreatic islets
Yi Cheng, Hong Zhu, Jun Ren, et al.
Oncology Letters
|
October 29, 2021
MI-773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1
Yan-Ling Chen, Zi-Mu Zhang, Xiao-Lu Li, et al.
Cell & Bioscience
|
March 19, 2022
BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
Yan-Ling Chen, Xiao-Lu Li, Gen Li, et al.
Cancer Cell International
|
November 8, 2021
CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
You Jiang, Shui-Yan Wu, Yan-Ling Chen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 2, 2023
A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects
Xin-Mei Yang, Yang Yang, Bu-Fan Yao, et al.
The Lancet Regional Health. Western Pacific
|
November 6, 2023
Real-world tobacco cessation practice in China: findings from the prospective, nationwide multicenter China National Tobacco Cessation Cohort Study (CNTCCS)
Zhao Liu, Rui Qin, Xue-Jun Hu, et al.
JAMA
|
December 10, 2020
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial
Xi Wang, Shu-Sen Wang, Heng Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2020
An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy
Yun Wang, Yan-Yu Cai, Tobias Herold, et al.
Breast Cancer (Dove Medical Press)
|
April 17, 2024
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
Ying Chen, Wen-Xia Li, Jia-Hua Wu, et al.
BMJ Open
|
April 2, 2021
Study protocol for the Sino-Canadian Healthy Life Trajectories Initiative (SCHeLTI): a multicentre, cluster-randomised, parallel-group, superiority trial of a multifaceted community-family-mother-child intervention to prevent childhood overweight and obesity
Yanting Wu, Isabelle Marc, Luigi Bouchard, et al.
Page
of 58